Investment business

Possesses real-time analysis technology of the intestinal microbial ecosystem

Data standardization, development of the first standardized integrated technology solution

Provides high-quality, high-density data and time-series data processing and analysis products

Research and development of cancer and tumor treatment and adjuvant treatment

Antigen for research cancer treatment, immune regulation

Clinical trials using the developed treatment

(acquisition of 9.6 billion won / sale of 34 billion won, profit of 24.4 billion won)

Possess the technology to raise fish with light

Eco-friendly biopharmaceutical technology that is pollution-free and chemical-free